Impact of adverse drug reactions on the treatment pathways of early rheumatoid arthritis patients: a prospective observational cohort study.

Kimberly Velthuis Fenna Poppelaars Peter M Ten Klooster Harald E Vonkeman Naomi T Jessurun

Published in: Expert opinion on drug safety (2023)

Treatment pathways increase in complexity over time. Differences were found between patients with and without ADRs, with patients that experience ADRs receiving more and shorter treatments.

Keyphrases

adverse drug
rheumatoid arthritis patients
end stage renal disease
ejection fraction
newly diagnosed
emergency department
disease activity
rheumatoid arthritis
prognostic factors
electronic health record
replacement therapy